Blocking Key Enzyme in Cancer Cells Could Lead to New Therapy

News   Aug 06, 2013

 
Blocking Key Enzyme in Cancer Cells Could Lead to New Therapy
 
 
 

RELATED ARTICLES

Protein's Role in Mitochondrial Metabolism Identified

News

EXD2, a protein previously thought to be localised to the nucleus, has a key role in the production of proteins by mitochondria.

READ MORE

Glythera Appoints Chief Scientific Officer and Strengthens SAB

News

Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.

READ MORE

New Treatment Target for Melanoma

News

Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE